| http://identifiers.org/pubm... | rdf:type | biopax3:PublicationXref | lld:biopax3 |
| http://identifiers.org/pubm... | biopax3:author | Rubin CM | lld:biopax3 |
| http://identifiers.org/pubm... | biopax3:author | Baltimore D | lld:biopax3 |
| http://identifiers.org/pubm... | biopax3:author | Westbrook CA | lld:biopax3 |
| http://identifiers.org/pubm... | biopax3:author | Bernards A | lld:biopax3 |
| http://identifiers.org/pubm... | biopax3:author | Paskind M | lld:biopax3 |
| http://identifiers.org/pubm... | biopax3:db | PubMed | lld:biopax3 |
| http://identifiers.org/pubm... | biopax3:id | 3313010 | lld:biopax3 |
| http://identifiers.org/pubm... | biopax3:source | Mol Cell Biol 7(9);3231-6 | lld:biopax3 |
| http://identifiers.org/pubm... | biopax3:title | The first intron in the human c-abl gene is at least 200 kilobases long and is a target for translocations in chronic myelogenous leukemia. | lld:biopax3 |
| http://identifiers.org/pubm... | biopax3:year | 1987 | lld:biopax3 |
| http://biocyc.org/biopax/bi... | biopax3:xref | http://identifiers.org/pubm... | lld:biopax3 |
